Microfluidic Devices Market Analysis by Product Overview, Sales, Cost and Capacity, Forecast To 2025
Microfluidic Devices Market Analysis by Product Overview, Sales, Cost and Capacity, Forecast To 2025
The global Microfluidic Devices Market is growing rapidly and is expected to reach USD
13.24 billion. Over the last few years, the microfluidic devices have played an important role
in the pharmaceutical industry, especially, in the processes of drug discovery, development
and delivery. This has helped to improve healthcare management and medical outcomes.
These devices can carry out reaction and detection at lower cost and with better efficiency.
Thus, the demand for these devices has increased from the pharmaceutical industry.
Additionally, overall market has been experiencing development due to recent product
invention, and partnerships and mergers by various industries. Biological and medical fields
are leading the market growth owing to high demand from these sectors. The global market
is expected to witness rapid growing due to wider applications in the field of pharmaceutical
industry, medical device industry, and in-vitro diagnostic industry. Furthermore, increasing
awareness regarding the importance of controlled drug delivery is likely to add fuel to the
global microfluidic devices market growth.
Various materials are used to make microfluidic devices such as glass, polymer, ceramics,
and silicon. The fabrication techniques for silicon and glass microfluidic devices are
improving, making them demanding materials for manufacturing devices. The devices are
improving with improved fabrication techniques used for the manufacturing of silicon and
glass microfluidic devices. Therefore, it is providing opportunities to new entrants to come
up with innovating idea, which, in turn, is likely to boost the demand for the devices.
Some of the major participants of this market are Abbott, Agilent technologies, Inc, Bio-Rad
Laboratories, Inc., Cepheid, Dolomite Centre, F. Hoffmann-La Roche AG, Fluidigm
Corporation, Micronit microfluidics, Raindance Technologies, Inc, Siemens Healthcare GmbH
and others.
Regional Analysis
The global microfluidic devices market is segmented into North America, Europe, and Asia
Pacific.
North America was leading market player across the globe in 2016 and is expected to reach
USD 4.88 billion by the end of the forecasted period.
Europe is the second largest region in the global microfluidic devices market, which is
expected to grow at a CAGR of 22.8%.
Asia Pacific region is expected to be the fastest growing region in the global microfluidic
devices market.
Segmentation
Microfluidic devices market has been segmented on the basis of industry, which comprises
of in-vitro diagnostics, pharmaceutical, medical devices. On basis of the materials, market is
segmented into polymer, glass, silicon. On the basis of the application, the market is
segmented into clinical, and veterinary diagnostics, point of care, analytical devices, drug
delivery, environmental, and industrial applications. On the basis of geographic region, the
microfluidic devices market is segmented into three key regions: North America, Europe, and
Asia.
Brows More Research Reports at:
Contact:
Akash Anand
Email: [email protected]